Ariel Johnson, PhD
Chief Financial Officer
- MedTech finance and strategy leader with expertise in valuation, market opportunity analysis, and corporate growth planning, driving multiple ventures from launch to acquisition.
- Former VP at Endotronix, where she led strategic planning, investor relations, and diligence efforts culminating in a $700M acquisition by Edwards Lifesciences.